Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated ...
NYU Langone-led international study featured at ACC.26 supports combining advanced imaging to guide diagnosis and care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results